Pricing Log in Create free account

Cingulate Inc. (CING) vs Pliant Therapeutics, Inc. (PLRX)

Cingulate Inc. and Pliant Therapeutics, Inc. are both Biotechnology companies. Cingulate Inc. and Pliant Therapeutics, Inc. are of similar size ($63.8M and $60.2M). Across the 8 metrics below, Cingulate Inc. leads on 4 and Pliant Therapeutics, Inc. on 4.

Valuation

Metric CING PLRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 11.09 9.71
P/B 2.43 0.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.76 0.64
EV/Sales n/m (14.31) 9.21
Earnings yield (82.91%) (165.56%) (33.15%)
Free cash flow yield (36.67%) (126.73%) (25.50%)

Profitability

Metric CING PLRX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (198.74%) (50.29%) (56.36%)
Return on assets (123.76%) (37.69%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CING PLRX Biotechnology median
Revenue growth (TTM) — (48.95%) 6.02%
EPS growth (last fiscal year) 56.47% 29.97% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CING PLRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.50 9.90 4.72
Net debt to EBITDA 0.51 1.27 0.96

Dividend

Metric CING PLRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CING PLRX Biotechnology median
Market cap 63.84m 60.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack